Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Despite Stock Drop, Obama Budget Not Expected To Tangibly Impact Medtech

This article was originally published in The Gray Sheet

Executive Summary

Market confidence in the medical device sector declined, at least in the short term, in response to the Obama administration's fiscal 2010 budget proposal in late February, but analysts say investors are overreacting to very abstract risks to the industry

You may also be interested in...



Device Industry Continues Push To Influence Health Care Reform Dialogue

With comprehensive U.S. health care reform being viewed as a realistic near-term objective among key figures on Capitol Hill, a seat at the decision-making table is perhaps the best any one interest group could hope for - and signs suggest device firms have not been left idly standing

Device Industry Continues Push To Influence Health Care Reform Dialogue

With comprehensive U.S. health care reform being viewed as a realistic near-term objective among key figures on Capitol Hill, a seat at the decision-making table is perhaps the best any one interest group could hope for - and signs suggest device firms have not been left idly standing

Obama Budget Seeks Prior Authorization For Medicare Imaging

President Obama's budget proposal for fiscal year 2010 includes a plan for Medicare to contract with private third parties to pre-review and approve imaging payments on a scan-by-scan basis

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027182

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel